464 related articles for article (PubMed ID: 31686298)
1. Short-term dual antiplatelet therapy (DAPT) followed by P2Y12 monotherapy versus traditional DAPT in patients undergoing percutaneous coronary intervention: meta-analysis and viewpoint.
Wernly B; Rezar R; Gurbel P; Jung C
J Thromb Thrombolysis; 2020 Jan; 49(1):173-176. PubMed ID: 31686298
[TBL] [Abstract][Full Text] [Related]
2. P2Y12 Inhibitor Monotherapy After a Short Dual Antiplatelet Therapy Versus Standard-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Meta-Analysis.
Ho AC; Egolum U; Parker S; Dimmel J; Hawkins A; Ling H
Clin Drug Investig; 2020 Sep; 40(9):799-808. PubMed ID: 32661914
[TBL] [Abstract][Full Text] [Related]
3. Effect of P2Y12 inhibitor monotherapy versus dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: systematic review and meta-analysis.
Wu XT; He RR; Liang SZ; Ye GY; Ding SB
Minerva Med; 2020 Apr; 111(2):173-180. PubMed ID: 32338843
[TBL] [Abstract][Full Text] [Related]
4. Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis.
Khan SU; Singh M; Valavoor S; Khan MU; Lone AN; Khan MZ; Khan MS; Mani P; Kapadia SR; Michos ED; Stone GW; Kalra A; Bhatt DL
Circulation; 2020 Oct; 142(15):1425-1436. PubMed ID: 32795096
[TBL] [Abstract][Full Text] [Related]
5. Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials.
Giacoppo D; Matsuda Y; Fovino LN; D'Amico G; Gargiulo G; Byrne RA; Capodanno D; Valgimigli M; Mehran R; Tarantini G
Eur Heart J; 2021 Jan; 42(4):308-319. PubMed ID: 33284979
[TBL] [Abstract][Full Text] [Related]
6. Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.
Hahn JY; Song YB; Oh JH; Chun WJ; Park YH; Jang WJ; Im ES; Jeong JO; Cho BR; Oh SK; Yun KH; Cho DK; Lee JY; Koh YY; Bae JW; Choi JW; Lee WS; Yoon HJ; Lee SU; Cho JH; Choi WG; Rha SW; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Lee SH; Gwon HC;
JAMA; 2019 Jun; 321(24):2428-2437. PubMed ID: 31237645
[TBL] [Abstract][Full Text] [Related]
7. P2Y
Gragnano F; Mehran R; Branca M; Franzone A; Baber U; Jang Y; Kimura T; Hahn JY; Zhao Q; Windecker S; Gibson CM; Kim BK; Watanabe H; Song YB; Zhu Y; Vranckx P; Mehta S; Hong SJ; Ando K; Gwon HC; Calabrò P; Serruys PW; Dangas GD; McFadden EP; Angiolillo DJ; Heg D; Valgimigli M;
J Am Coll Cardiol; 2023 Feb; 81(6):537-552. PubMed ID: 36754514
[TBL] [Abstract][Full Text] [Related]
8. Abbreviated Dual Antiplatelet Therapy Followed by P2Y
Kumar A; Shariff M; Doshi R; Vaz IP
Am J Cardiovasc Drugs; 2020 Aug; 20(4):355-361. PubMed ID: 31784888
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of Dual Antiplatelet Therapy Versus Monotherapy With P2Y12 Inhibitors in Patients After Percutaneous Coronary Intervention.
Malik AH; Yandrapalli S; Shetty SS; Aronow WS; Cooper HA; Panza JA
Am J Cardiol; 2020 Jul; 127():25-29. PubMed ID: 32389351
[TBL] [Abstract][Full Text] [Related]
10. P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trials.
Kuno T; Ueyama H; Takagi H; Bangalore S
Am Heart J; 2020 Sep; 227():82-90. PubMed ID: 32693196
[TBL] [Abstract][Full Text] [Related]
11. P2Y
Jin Y; Huang H; Shu X; Chen S; Lu L; Gao X; Wu Z
Thromb Res; 2021 Feb; 198():115-121. PubMed ID: 33316640
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of P2Y
Casula M; Casu G; Talanas G; Spano A; Tantry U; Bilotta F; Micheluzzi V; Merella P; Porcheddu T; Gorog DA; Bonaca M; Jeong YH; Farkouh ME; Kubica J; Isgender M; Gurbel PA; Navarese EP
Curr Probl Cardiol; 2024 Aug; 49(8):102635. PubMed ID: 38750991
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis.
Nicolas J; Dangas G; Chiarito M; Pivato CA; Spirito A; Cao D; Giustino G; Beerkens F; Camaj A; Vogel B; Sartori S; Yamamoto K; Kimura T; Kim BK; Baber U; Mehran R
Eur Heart J Cardiovasc Pharmacother; 2023 Apr; 9(3):240-250. PubMed ID: 36564015
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of P2Y12 inhibitor monotherapy in patients after percutaneous coronary intervention.
Luo L; Fu M; Li Y; Chen Z; Yu J; Luo J; Hu S; Tu L; Xu X
Clin Cardiol; 2020 Mar; 43(3):235-241. PubMed ID: 31777973
[TBL] [Abstract][Full Text] [Related]
15. Sex-Based Outcomes of P2Y12 Inhibitor Monotherapy After Three Months of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention.
Shin ES; Her AY; Kim B; Hahn JY; Song YB; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Lee SH; Gwon HC;
J Korean Med Sci; 2023 Nov; 38(45):e383. PubMed ID: 37987108
[TBL] [Abstract][Full Text] [Related]
16. P2Y
Andò G; De Santis GA; Greco A; Pistelli L; Francaviglia B; Capodanno D; De Caterina R; Capranzano P
JACC Cardiovasc Interv; 2022 Nov; 15(22):2239-2249. PubMed ID: 36423966
[TBL] [Abstract][Full Text] [Related]
17. Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All-Cause Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention.
McClure JD; Ramsay JC; Berry C
J Am Heart Assoc; 2020 Aug; 9(16):e017109. PubMed ID: 32779497
[TBL] [Abstract][Full Text] [Related]
18. Aspirin-free antiplatelet strategies after percutaneous coronary interventions.
Capranzano P; Moliterno D; Capodanno D
Eur Heart J; 2024 Feb; 45(8):572-585. PubMed ID: 38240716
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis.
Gelbenegger G; Schoergenhofer C; Jilma B; Gager GM; Dizdarevic AM; Mamas MA; Parapid B; Velagapudi P; Siller-Matula JM
Clin Pharmacol Ther; 2021 Aug; 110(2):424-431. PubMed ID: 33668076
[TBL] [Abstract][Full Text] [Related]
20. Meta-Analysis of the Efficacy and Safety of P2Y
Elzanaty AM; Nazir S; Awad MT; Elsheikh E; Ahuja KR; Donato A; Eltahawy EA
Cardiovasc Revasc Med; 2020 Dec; 21(12):1500-1506. PubMed ID: 32457020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
